
| Category | Testing Item | BRC Method | Regulatory Compliance |
|---|---|---|---|
| Viability | Cell Vialbility | Cell Counting | |
| Cell Morphylogy | Microscopic Examination | ||
| Identity | CO1 Barcoding | Multiplex PCR Sanger Seqencing |
USP, EP, ChP |
| Purity | Sterility |
Direct Inoculation Method Membrane Filtration Method Rapid Ster |
USP, EP, ChP |
| Mycoplasma |
Agar & Non-agar Cultivation qPCR Rapid Testing |
USP, EP, ChP | |
| Mycobacterium |
in vitro Indicate Cell-based Assay in vivo Assay NGS-based Assa |
||
| Safety | Adventitious Viruses | in vitro Indicate Cell-based Assay in vivo Assay NGS-based Assa |
USP, EP, ChP |
| Retrovirus | Cell-based Infectivity Assay Transmission Electron Microscopy (TEM) PERT Assay |
USP, EP, ChP | |
| Rodent-specific Pathogens |
Antibody Production Test (MAP, HAP, RAP) Rodent Pathogen qPCR Panel Targeted NGS* |
USP, EP, ChP | |
| Bovine & Porcine Pathogens |
Cell-based Infectivity Assay Bovine & Porcine Pathogens qPCR Panel |
9CFR | |
|
* NGS-based Assay and Targeted NGS are conducted on BRC NGenius®
Platform
|
|||